Evidence map›Paper›PMID 31464641›Full record

ArticleJournal of translational medicine2019

Cryopreserved mesenchymal stem cells regain functional potency following a 24-h acclimation period.

Ben Antebi, Amber M Asher, Luis A Rodriguez, Robbie K Moore, Arezoo Mohammadipoor, Leopoldo C Cancio

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Mesenchymal Stem Cells and Psoriasis: Systematic Review.International journal of molecular sciences · 2022
    Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ben AntebiUnited States Army Institute of Surgical Research, 3698 Chambers Pass BLDG 3610, JBSA Fort Sam Houston, San Antonio, TX, 78234, USA. benantebi@gmail.com.ORCID 0000-0002-2062-5206
Amber M AsherUnited States Army Institute of Surgical Research, 3698 Chambers Pass BLDG 3610, JBSA Fort Sam Houston, San Antonio, TX, 78234, USA.
Luis A RodriguezUnited States Army Institute of Surgical Research, 3698 Chambers Pass BLDG 3610, JBSA Fort Sam Houston, San Antonio, TX, 78234, USA.
Robbie K MooreUnited States Army Institute of Surgical Research, 3698 Chambers Pass BLDG 3610, JBSA Fort Sam Houston, San Antonio, TX, 78234, USA.
Arezoo MohammadipoorUnited States Army Institute of Surgical Research, 3698 Chambers Pass BLDG 3610, JBSA Fort Sam Houston, San Antonio, TX, 78234, USA.
Leopoldo C CancioUnited States Army Institute of Surgical Research, 3698 Chambers Pass BLDG 3610, JBSA Fort Sam Houston, San Antonio, TX, 78234, USA.
United States Army Institute of Surgical Research · USOak Ridge Associated Universities · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMesenchymal stem cells (MSCs) are attractive cell-therapy candidates. Despite their popularity and promise, there is no uniform method of preparation of MSCs. Typically, cells are cryopreserved in liquid nitrogen, thawed, and subsequently administered to a patient with little to no information on their function post-thaw. We hypothesized that a short acclimation period post-thaw will facilitate the recovery of MSC's functional potency.

methodsHuman bone-marrow-derived MSCs were divided into 3 groups: FC (fresh cells; from existing culture); TT (thawed + time; acclimated for 24 h post-thaw); and FT (freshly thawed; thawed and immediately used). The 3 groups were analyzed for their cellular and functional potency.

resultsPhenotypic analysis demonstrated a decrease in CD44 and CD105 surface markers in FT MSCs, with no change in the other two groups. All MSCs were able to differentiate down the osteogenic and chondrogenic lineages. In FT cells, metabolic activity and apoptosis was significantly increased with concomitant decrease in cell proliferation; clonogenic capacity; and key regenerative genes. Following 24-h acclimation, apoptosis was significantly reduced in TT cells with a concomitant upregulation in angiogenic and anti-inflammatory genes. While all MSCs significantly arrested T-cell proliferation, the TT MSCs were significantly more potent. Similarly, although all MSCs maintained their anti-inflammatory properties, IFN-γ secretion was significantly diminished in FT cells.

conclusionsThese data demonstrate that FT MSCs maintain their multipotent differentiation capacity, immunomodulatory function, and anti-inflammatory properties; yet, various aspects of cell characteristics and function are deleteriously affected by cryopreservation. Importantly, a 24-h acclimation period 'reactivates' thawed cells to recover their diminished stem-cell function.

Indexed as

CryopreservationAnti-Inflammatory AgentsApoptosisCell DifferentiationCell ProliferationClone CellsGene Expression RegulationHumansImmunophenotypingImmunosuppression TherapyMesenchymal Stem CellsMultipotent Stem CellsTime FactorsAnti-Inflammatory AgentsAcclimationCell therapyCryopreservationFreshly thawedMesenchymal stem cells

Identifiers

PMID31464641
PMCPMC6716839
OpenAlexW2970636913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.